REG - Hellenic Dynamics - Result of AGM

Hellenic DynamicsAnnouncement

29/09/2023 15:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230929:nRSc2268Oa&default-theme=true

RNS Number : 2268O  Hellenic Dynamics PLC  29 September 2023

Hellenic Dynamics plc

("Hellenic Dynamics" or the "Company")

 

Result of Annual General Meeting ("AGM")

 

Hellenic Dynamics Plc (LSE: HELD), a medical cannabis cultivator with a
dedicated focus on producing tetrahydrocannabinol ("THC") dominant strains of
medical cannabis flowers for the burgeoning European medical cannabis markets,
is pleased to announce that all resolutions put to the AGM were passed by
shareholders on a show of hands. The proxy results received ahead of the AGM
were:

 

 

 Resolution                                                                  For                    Against             Withheld    Total votes cast
                                                                             No. of votes   %       No. of votes  %

 ORDINARY RESOLUTIONS
 1.   To receive the Company's annual report and accounts for the period     1,955,917,606  100.00  0             0.00  440,466     1,955,917,606
 ended 31 March 2023

 2.   To approve the Directors' Remuneration Policy                          1,946,616,811  99.95   1,068,295     0.05  8,672,966   1,947,685,106

 3.   To approve the Remuneration Report                                     1,946,629,311  99.95   1,055,795     0.05  8,672,966   1,947,685,106

 4.   To re-appoint Sir Anthony Joliffe                                      1,946,856,246  99.57   8,456,034     0.43  1,045,792   1,955,312,280

 5.  To re-appoint Mr Davinder Rai                                           1,954,623,746  99.96   688,534       0.04  1,045,792   1,955,312,280

 6.  To re-appoint Mr Filippos Papadopoulos                                  1,954,629,311  99.97   682,969       0.03  1,045,792   1,955,312,280

 7.  To re-appoint Mr Joseph Colliver                                        1,954,623,746  99.98   456,034       0.02  1,278,292   1,955,079,780

 8.   To re-appoint PFK Littlejohn LLP                                       1,955,467,137  99.98   450,469       0.02  440,466     1,955,917,606

 9.   To authorise the Directors to determine the auditor's remuneration     1,955,917,606  100.00  0             0.00  440,466     1,955,917,606

 10.  To authorise the Directors to allot shares                             1,935,355,786  99.95%  918,068       0.05  20,084,218  1,936,273,854

 SPECIAL RESOLUTIONS

 11.  To authorise the Directors to disapply pre-emption rights              1,934,702,476  99.92   1,571,378     0.08  20,084,218  1,936,273,854

 12.  To authorise calling of a general meeting other than annual general    1,954,196,001  99.94   1,103,779     0.06  1,058,292   1,955,299,780
 meetings on 14 clear days' notice

Notes:

 

A vote withheld is not a vote in law and is not counted in the calculation of
the percentage of the votes validly cast for or against a resolution.

 

Enquires:

 

Hellenic Dynamics plc
                        +44 (0)20 3818 7850

Davinder Rai
 
                        davinder@hellenicdynamics.com

 

Cairn Financial Advisers LLP

Emily Staples / Jo Turner
 
            +44 (0)20 7213 0880

 

Peterhouse Capital

Lucy Williams / Charles Goodfellow
                        +44 (0)20 7469 0930

 

 

About Hellenic Dynamics plc
 
Founded in 2019, Hellenic Dynamics is specifically focused on the cultivation
and supply of THC ("tetrahydrocannabinol") - dominant strains of medical
cannabis flowers, destined for the growing medical cannabis markets
across Europe. Hellenic Dynamics' core strategy is to develop and operate its
40,000 square metre active cultivation licence from its 195,506 square metre
facility located near Thessaloniki in Northern Greece. In full production,
Hellenic Dynamics is capable of producing over 54,000 kg of dried flowers per
annum.
 
Hellenic Dynamics will take advantage of its relatively low cost base
resulting from a comparatively low cost of power, having its own running
water supply and the labour rates for skilled and semi-skilled labour in
Northern Greece.
 
25 European countries now allow medical cannabis via prescription and the
European cannabis market is expected to reach €43.3 billion per annum by
2027. Sales of Hellenic Dynamics' dried THC-dominant cannabis flowers and
extracts are initially intended for export into Europe's largest market -
Germany, in addition to other European markets including domestically in
Greece.
 
As the first medical cannabis cultivator to obtain a listing on the main
market for listed securities of the London Stock Exchange,
Hellenic Dynamics is significantly different to the number of CBD
(Cannabidiol) related companies that have appeared over the recent
years. Hellenic Dynamics cultivates THC-dominant medical cannabis flowers.
THC-dominant medical cannabis products are only available via a medical
prescription. Medicinal cannabis has been approved for use both in the United
Kingdom and Germany, plus 23 other European countries, for conditions
including but not limited to  chronic pain, intractable chemotherapy-related
nausea, anxiety, insomnia, Tourette's syndrome, substance use disorder,
multiple sclerosis, IBS, spinal cord treatment, lack of appetite due to
HIV/AIDS, cachexia, anorexia and glaucoma.

For further information please visit our website www.hellenicdynamics.com
(http://www.hellenicdynamics.com/)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGLLMITMTBTBAJ